These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 25929923)

  • 1. Prevalence and risk factors of cognitive impairment in Parkinson disease: a population-based case-control study in Taiwan.
    Huang YC; Wu ST; Lin JJ; Lin CC; Kao CH
    Medicine (Baltimore); 2015 May; 94(17):e782. PubMed ID: 25929923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Premotor cognitive status in a cohort of incident Parkinson disease patients (NEDICES).
    Sánchez-Ferro Á; Benito-León J; Mitchell AJ; Louis ED; Posada IJ; Trincado R; Villarejo A; Bermejo-Pareja F
    J Neurol Sci; 2011 Nov; 310(1-2):211-5. PubMed ID: 21621225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cognitive impairment in 873 patients with idiopathic Parkinson's disease. Results from the German Study on Epidemiology of Parkinson's Disease with Dementia (GEPAD).
    Riedel O; Klotsche J; Spottke A; Deuschl G; Förstl H; Henn F; Heuser I; Oertel W; Reichmann H; Riederer P; Trenkwalder C; Dodel R; Wittchen HU
    J Neurol; 2008 Feb; 255(2):255-64. PubMed ID: 18204803
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Natural course of mild cognitive impairment in Parkinson disease: A 5-year population-based study.
    Pedersen KF; Larsen JP; Tysnes OB; Alves G
    Neurology; 2017 Feb; 88(8):767-774. PubMed ID: 28108638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence of and risk factors for cognitive impairment in an early Parkinson disease clinical trial cohort.
    Uc EY; McDermott MP; Marder KS; Anderson SW; Litvan I; Como PG; Auinger P; Chou KL; Growdon JC;
    Neurology; 2009 Nov; 73(18):1469-77. PubMed ID: 19884574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive impairment in incident, untreated Parkinson disease: the Norwegian ParkWest study.
    Aarsland D; Brønnick K; Larsen JP; Tysnes OB; Alves G;
    Neurology; 2009 Mar; 72(13):1121-6. PubMed ID: 19020293
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Cognition deterioration in Parkinson's disease: associated risk factors].
    Errea JM; Ara JR
    Rev Neurol; 1999 Mar 1-15; 28(5):439-43. PubMed ID: 10229953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk of cognitive impairment or dementia in relatives of patients with Parkinson disease.
    Rocca WA; Bower JH; Ahlskog JE; Elbaz A; Grossardt BR; McDonnell SK; Schaid DJ; Maraganore DM
    Arch Neurol; 2007 Oct; 64(10):1458-64. PubMed ID: 17923629
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Frequency and Correlates of Subjective Memory Complaints in Parkinson's Disease with and without Mild Cognitive Impairment: Data from the Parkinson's Disease Cognitive Impairment Study.
    Baschi R; Nicoletti A; Restivo V; Recca D; Zappia M; Monastero R
    J Alzheimers Dis; 2018; 63(3):1015-1024. PubMed ID: 29710711
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cognitive performance and neuropsychiatric symptoms in early, untreated Parkinson's disease.
    Weintraub D; Simuni T; Caspell-Garcia C; Coffey C; Lasch S; Siderowf A; Aarsland D; Barone P; Burn D; Chahine LM; Eberling J; Espay AJ; Foster ED; Leverenz JB; Litvan I; Richard I; Troyer MD; Hawkins KA;
    Mov Disord; 2015 Jun; 30(7):919-27. PubMed ID: 25737166
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetes mellitus is independently associated with more severe cognitive impairment in Parkinson disease.
    Bohnen NI; Kotagal V; Müller ML; Koeppe RA; Scott PJ; Albin RL; Frey KA; Petrou M
    Parkinsonism Relat Disord; 2014 Dec; 20(12):1394-8. PubMed ID: 25454317
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognosis of mild cognitive impairment in early Parkinson disease: the Norwegian ParkWest study.
    Pedersen KF; Larsen JP; Tysnes OB; Alves G
    JAMA Neurol; 2013 May; 70(5):580-6. PubMed ID: 23529397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pacific Northwest Udall Center of excellence clinical consortium: study design and baseline cohort characteristics.
    Cholerton BA; Zabetian CP; Quinn JF; Chung KA; Peterson A; Espay AJ; Revilla FJ; Devoto J; Watson GS; Hu SC; Edwards KL; Montine TJ; Leverenz JB
    J Parkinsons Dis; 2013; 3(2):205-14. PubMed ID: 23938350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Olfactory dysfunction and dementia in newly diagnosed patients with Parkinson's disease.
    Domellöf ME; Lundin KF; Edström M; Forsgren L
    Parkinsonism Relat Disord; 2017 May; 38():41-47. PubMed ID: 28242255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dementia and cognitive impairment in patients with Parkinson's disease from India: a 7-year prospective study.
    Sanyal J; Banerjee TK; Rao VR
    Am J Alzheimers Dis Other Demen; 2014 Nov; 29(7):630-6. PubMed ID: 24771763
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A registry-based, case-control investigation of Parkinson's disease with and without cognitive impairment.
    Papapetropoulos S; Ellul J; Polychronopoulos P; Chroni E
    Eur J Neurol; 2004 May; 11(5):347-51. PubMed ID: 15142230
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Educational level and cognitive impairment in patients with Parkinson disease.
    Kierzynka A; Kaźmierski R; Kozubski W
    Neurol Neurochir Pol; 2011; 45(1):24-31. PubMed ID: 21384290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between homocysteine and third ventricle dilatation, mesencephalic area atrophy in Parkinson's disease with cognitive impairment.
    Fu XY; Zhang YC; Ding CW; Yang M; Song X; Wang CS; Chen XF; Zhang Y; Sheng YJ; Mao P; Mao CJ; Liu CF
    J Clin Neurosci; 2021 Aug; 90():273-278. PubMed ID: 34275563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of dementia after Parkinson's disease in Taiwan: a population-based retrospective cohort study using National Health Insurance claims.
    Liu CC; Sun Y; Lee PC; Li CY; Hu SC
    BMJ Open; 2019 Mar; 9(3):e025274. PubMed ID: 30833322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Occurrence and risk factors for apathy in Parkinson disease: a 4-year prospective longitudinal study.
    Pedersen KF; Alves G; Aarsland D; Larsen JP
    J Neurol Neurosurg Psychiatry; 2009 Nov; 80(11):1279-82. PubMed ID: 19864662
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.